Khrom Capital urges Acadia Healthcare to explore sale

Core Viewpoint - Khrom Capital Management, a major shareholder of Acadia Healthcare, is urging the company's board to initiate a formal strategic review, which may include a potential sale, due to years of underperformance [1] Group 1 - Khrom Capital Management is one of the largest shareholders of Acadia Healthcare [1] - The call for a strategic review is based on the company's prolonged poor performance [1] - The potential sale is part of the strategic options being considered [1]